Skip to content
Moxidectin
Moxidectin is a small molecule pharmaceutical. Moxidectin was first approved as Moxidectin on 2018-06-13. It is used to treat ocular onchocerciasis in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
eye diseasesD005128
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Moxidectin
Tradename
Company
Number
Date
Products
MOXIDECTINMedicines Development for Global HealthN-210867 RX2018-06-13
1 products, RLD, RS
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
ocular onchocerciasisEFO_0007398D015827B73
Agency Specific
FDA
EMA
Expiration
Code
MOXIDECTIN, MOXIDECTIN, MDGH
2025-06-13ODE-193
2023-06-13NCE
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
— P02: Anthelmintics
— P02C: Antinematodal agents
— P02CX: Other antinematodals in atc
— P02CX03: Moxidectin
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMOXIDECTIN
INNmoxidectin
Description
Moxidectin is a milbemycin.
Classification
Small molecule
Drug classantiparasitics (ivermectin type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CO/N=C1\C[C@]2(C[C@@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C
Identifiers
PDB—
CAS-ID113507-06-5
RxCUI—
ChEMBL IDCHEMBL2104415
ChEBI ID—
PubChem CID9832912
DrugBankDB11431
UNII IDNGU5H31YO9 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,744 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details